|
1
|
Gu ML, Zhou XX, Ren MT, Shi KD, Yu MS,
Jiao WR, Wang YM, Zhong WX and Ji F: Blockage of ETS homologous
factor inhibits the proliferation and invasion of gastric cancer
cells through the c-Met pathway. World J Gastroenterol.
26:7497–7512. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Polkowska-Pruszyńska B, Rawicz-Pruszyński
K, Ciseł B, Sitarz R, Polkowska G, Krupski W and Polkowski WP:
Liver metastases from gastric carcinoma: A Case report and review
of the literature. Curr Probl Cancer. 41:222–230. 2017. View Article : Google Scholar
|
|
3
|
Zhao J, Zhao J, Du F, Zhang Y, Shen G, Zhu
H, Ji F, Ma F, Dong L, Kan J, et al: Cardia and non-cardia gastric
cancer have similar stage-for-stage prognoses after R0 resection: A
large-scale, multicenter study in China. J Gastrointest Surg.
20:700–707. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: An alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Altorki NK, Markowitz GJ, Gao D, Port JL,
Saxena A, Stiles B, McGraw T and Mittal V: The lung
microenvironment: An important regulator of tumour growth and
metastasis. Nat Rev Cancer. 19:9–31. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang H, Yuan M, Wu SL, Ba J, Yu X, Mao X
and Jin F: Clinical significance of C-X-C motif chemokine receptor
4 and integrin αvβ6 expression in breast cancer. J Breast Cancer.
23:171–181. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu C, Zhao H, Chen H and Yao Q: CXCR4 in
breast cancer: Oncogenic role and therapeutic targeting. Drug Des
Devel Ther. 9:4953–4964. 2015.PubMed/NCBI
|
|
9
|
Stumpf C, Kaemmerer D, Neubauer E, Sänger
J, Schulz S and Lupp A: Somatostatin and CXCR4 expression patterns
in adenocarcinoma and squamous cell carcinoma of the lung relative
to small cell lung cancer. J Cancer Res Clin Oncol. 144:1921–1932.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lecavalier-Barsoum M, Chaudary N, Han K,
Koritzinsky M, Hill R and Milosevic M: Targeting the CXCL12/CXCR4
pathway and myeloid cells to improve radiation treatment of locally
advanced cervical cancer. Int J Cancer. 143:1017–1028. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nazari A, Khorramdelazad H and Hassanshahi
G: Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes
in the pathogenesis of bladder cancer. Int J Clin Oncol.
22:991–1000. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li LN, Jiang KT, Tan P, Wang AH, Kong QY,
Wang CY, Lu HR and Wang J: Prognosis and clinicopathology of CXCR4
in colorectal cancer patients: A meta-analysis. Asian Pac J Cancer
Prev. 16:4077–4080. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang Q, Sun Y and Liu X: CXCR4 as a
prognostic biomarker in gastrointestinal cancer: A meta-analysis.
Biomarkers. 24:510–516. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xiang Z, Zhou ZJ, Xia GK, Zhang XH, Wei
ZW, Zhu JT, Yu J, Chen W, He Y, Schwarz RE, et al: A positive
crosstalk between CXCR4 and CXCR2 promotes gastric cancer
metastasis. Oncogene. 36:5122–5133. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Albalawi IA, Mir R and Abu Duhier FM:
Genetic effects of vascular endothelial growth factor A (VEGF-A)
and its association with disease progression in breast cancer
population of Saudi Arabia. Asian Pac J Cancer Prev. 21:139–145.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Alagappan VK, Willems-Widyastuti A,
Seynhaeve AL, Garrelds IM, ten Hagen TL, Saxena PR and Sharma HS:
Vasoactive peptides upregulate mRNA expression and secretion of
vascular endothelial growth factor in human airway smooth muscle
cells. Cell Biochem Biophys. 47:109–118. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Eroğlu A, Ersöz C, Karasoy D and Sak S:
Vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and
D2-40 expressions in primary breast cancer: Association with lymph
node metastasis. Adv Clin Exp Med. 26:245–249. 2017. View Article : Google Scholar
|
|
18
|
Chen C, Chi H, Min L and Junhua Z:
Downregulation of guanine nucleotide-binding protein beta 1 (GNB1)
is associated with worsened prognosis of clearcell renal cell
carcinoma and is related to VEGF signaling pathway. J BUON.
22:1441–1446. 2017.PubMed/NCBI
|
|
19
|
Jain S, Ward MM, O'Loughlin J, Boeck M,
Wiener N, Chuang E, Cigler T, Moore A, Donovan D, Lam C, et al:
Incremental increase in VEGFR1* hematopoietic progenitor cells and
VEGFR2* endothelial progenitor cells predicts relapse and lack of
tumor response in breast cancer patients. Breast Cancer Res Treat.
132:235–242. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pan Z, Zhuang J, Ji C, Cai Z, Liao W and
Huang Z: Curcumin inhibits hepatocellular carcinoma growth by
targeting VEGF expression. Oncol Lett. 15:4821–4826.
2018.PubMed/NCBI
|
|
21
|
Naykoo NA, Dil-Afroze, Rasool R, Shah S,
Ahangar AG, Bhat IA, Qasim I, Siddiqi MA and Shah ZA: Single
nucleotide polymorphisms, haplotype association and tumour
expression of the vascular endothelial growth factor (VEGF) gene
with lung carcinoma. Gene. 608:95–102. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu W, Dong Z, Hu R and Wang C:
Association of vascular endothelial growth factor (VEGF) gene
polymorphisms with gastric cancer and its development, prognosis,
and survival. Technol Cancer Res Treat. Jan 1–2018.(Epub ahead of
print). doi: 10.1177/1533034617753810.
|
|
23
|
Pang L, Wang J, Fan Y, Xu R, Bai Y and Bai
L: Correlations of TNM staging and lymph node metastasis of gastric
cancer with MRI features and VEGF expression. Cancer Biomark.
23:53–59. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang S, Wu X, Chen Y, Zhang J, Ding J,
Zhou Y, He S, Tan Y, Qiang F, Bai J, et al: Prognostic and
predictive role of JWA and XRCC1 expressions in gastric cancer.
Clin Cancer Res. 18:2987–2996. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bai J, Zhou Y, Chen G, Zeng J, Ding J, Tan
Y, Zhou J and Li G: Overexpression of Cullin1 is associated with
poor prognosis of patients with gastric cancer. Hum Pathol.
42:375–383. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang W, Chen Y, Deng J, Zhou J, Gu X, Tang
Y, Zhang G, Tan Y, Ge Z, Huang Y, et al: Cullin1 is a novel
prognostic marker and regulates the cell proliferation and
metastasis in colorectal cancer. J Cancer Res Clin Oncol.
141:1603–1612. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pedersen LM, Klausen TW, Davidsen UH and
Johnsen HE: Early changes in serum IL-6 and VEGF levels predict
clinical outcome following first-line therapy in aggressive
non-Hodgkin's lymphoma. Ann Hematol. 84:510–516. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Capone F, Guerriero E, Sorice A, Colonna
G, Ciliberto G and Costantini S: Serum cytokinome profile
evaluation: A tool to define new diagnostic and prognostic markers
of cancer using multiplexed bead-based immunoassays. Mediators
Inflamm. 2016:30646432016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zeng XH, Ou ZL, Yu KD, Feng LY, Yin WJ, Li
J, Shen ZZ and Shao ZM: Absence of multiple atypical chemokine
binders (ACBs) and the presence of VEGF and MMP-9 predict axillary
lymph node metastasis in early breast carcinomas. Med Oncol.
31:1452014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sojane K, Kangethe RT, Chang CC, Moosa MS,
Lewin SR, French MA and Ndung'u T: Individuals with HIV-1 subtype C
infection and cryptococcal meningitis exhibit viral genetic
intermixing of HIV-1 between plasma and cerebrospinal fluid and a
high prevalence of CXCR4-using variants. AIDS Res Hum Retroviruses.
34:607–620. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen IX, Chauhan VP, Posada J, Ng MR, Wu
MW, Adstamongkonkul P, Huang P, Lindeman N, Langer R and Jain RK:
Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte
infiltration, and improves immunotherapy in metastatic breast
cancer. Proc Natl Acad Sci USA. 116:4558–4566. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rastegar M, Marjani HA, Yazdani Y,
Shahbazi M, Golalipour M and Farazmandfar T: Investigating effect
of rapamycin and metformin on angiogenesis in hepatocellular
carcinoma cell line. Adv Pharm Bull. 8:63–68. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Honguero Martínez AF, Arnau Obrer A,
Figueroa Almazán S, Martínez Hernández N and Guijarro Jorge R:
Prognostic value of the expression of vascular endothelial growth
factor A and hypoxia-inducible factor 1alpha in patients undergoing
surgery for non-small cell lung cancer. Med Clin (Barc).
142:432–437. 2014. View Article : Google Scholar
|
|
35
|
Chou JC, Lieu FK, Ho DM, Shen HY, Lin PH,
Hu S, Wang SW, Lin H and Wang PS: Regulation of extracellular and
intracellular prolactin on cell proliferation and survival rate
through GHR/JAK2/STAT3 pathway in NSCLC. Chemosphere.
264:1286042021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li H, Takayama K, Wang S, Shiraishi Y,
Gotanda K, Harada T, Furuyama K, Iwama E, Ieiri I, Okamoto I, et
al: Addition of bevacizumab enhances antitumor activity of
erlotinib against non-small cell lung cancer xenografts depending
on VEGF expression. Cancer Chemother Pharmacol. 74:1297–1305. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Baci D, Bruno A, Cascini C, Gallazzi M,
Mortara L, Sessa F, Pelosi G, Albini A and Noonan DM:
Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and
angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells:
Rationale for prevention and interception strategies. J Exp Clin
Cancer Res. 38:4642019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hong X, Jiang F, Kalkanis SN, Zhang ZG,
Zhang XP, DeCarvalho AC, Katakowski M, Bobbitt K, Mikkelsen T and
Chopp M: SDF-1 and CXCR4 are up-regulated by VEGF and contribute to
glioma cell invasion. Cancer Lett. 236:39–45. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bi MM, Shang B, Wang Z and Chen G:
Expression of CXCR4 and VEGF-C is correlated with lymph node
metastasis in non-small cell lung cancer. Thorac Cancer. 8:634–641.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Segawa Y, Oda Y, Yamamoto H, Shiratsuchi
H, Hirakawa N, Komune S and Tsuneyoshi M: Close correlation between
CXCR4 and VEGF expression and their prognostic implications in
nasopharyngeal carcinoma. Oncol Rep. 21:1197–1202. 2009.PubMed/NCBI
|
|
41
|
Wu Y, Jin M, Xu H, Shimin Z, He S, Wang L
and Zhang Y: Clinicopathologic significance of HIF-1α, CXCR4, and
VEGF expression in colon cancer. Clin Dev Immunol. 2010:5375312010.
View Article : Google Scholar : PubMed/NCBI
|
